The lack of patient adherence to prescribed medications and post-procedure care instructions is creating tremendous strain on both healthcare providers and payers alike. In recent research conducted by CapGemini, findings show that In the US alone, avoidable medical spending is estimated at over $300 billion per annum.
Solving the adherence gap is now an imperative for healthcare and life sciences companies to protect their businesses from increasing regulation and cost cutting pressures, and seize the opportunity to improve the overall patient experience. This is where AI and chatbots can have a direct impact on increasing the touchpoints with patients, and ensuring a feedback loop that drives the correct care actions and visibility into drug and care program adherence.
In this session, attendees will gain an understanding of:
- The root causes of non-adherence?
- How has the industry addressed non-adherence in the past?
- How do AI-driven Chatbots change the ways patient adherence can be addressed?
- What use cases have emerged from early adoption that the healthcare industry can learn from?